Unlocking microbiome secrets: a systematic review of microbiome-derived biomarkers for early colorectal cancer detection
Frontiers in Oncology · 20.11.2026 · 16
DOI: 10.3389/fonc.2026.1804433 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Frontiers in Oncology, online erschienen am 20.11.2026. Verfasst von Juliana Victoria Martinez Janne und 3 weiteren Autor:innen. Die Arbeit nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad del Tolima.
Abstract (Originalsprache)
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, and established non-invasive screening tools such as the guaiac fecal occult blood test and the fecal immunochemical test have limited sensitivity for early-stage disease. Microbiome-derived biomarkers have emerged as a promising alternative for early, non-invasive CRC detection. This systematic review evaluated the diagnostic performance of microbiome-derived biomarkers - including 16S rRNA gene sequencing, metagenomic shotgun sequencing, and co-metabolomic profiling - for detecting early-stage colorectal cancer and its precursor lesions. A systematic search of PubMed and EMBASE (via OVID) covering the ten years up to May 3, 2024 was conducted following PRISMA 2020 guidelines, with triplicate ASReview-assisted screening and two-of-three reviewer consensus for full-text selection; risk of bias was assessed using QUADAS-2. Of 3,859 records identified in the primary search, 26 studies met all eligibility criteria; following a post-hoc bibliographic verification and a subsequent targeted search update, the final set comprised 28 studies, drawn from East Asia, South Asia, Europe, and North America and predominantly using fecal samples, with a minority also using oral swab or serum samples. Reported diagnostic performance varied widely across studies (area under the curve 0.28-0.98; sensitivity 18-100%; specificity 39-97%), with the highest accuracy reported for panels derived from oral swab samples. Most studies carried a high or unclear risk of bias in the index-test domain, and no included study reported independent external validation of its biomarker panel in a separate cohort. Microbiome-derived biomarkers show promising but highly heterogeneous and largely unvalidated diagnostic performance for early CRC detection. Standardized sample-collection and analytic protocols, together with externally validated, multi-center studies in populations not yet represented in the evidence base - including South America - are needed before these biomarkers can be considered for clinical or population-level screening use.
Förderung
- Universidad del Tolima
Zitieren
APA
Janne, J. V. M., Lozano, M. B., Hussain, S. K., & Carvajal-Carmona, L. G. (2026). Unlocking microbiome secrets: a systematic review of microbiome-derived biomarkers for early colorectal cancer detection. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1804433
Vancouver
Janne JVM, Lozano MB, Hussain SK, Carvajal-Carmona LG. Unlocking microbiome secrets: a systematic review of microbiome-derived biomarkers for early colorectal cancer detection. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1804433
BibTeX
@article{Janne2026,
author = {Janne, Juliana Victoria Martinez and Lozano, Mabel Bohorquez and Hussain, Shehnaz K. and Carvajal-Carmona, Luis Guillermo},
title = {Unlocking microbiome secrets: a systematic review of microbiome-derived biomarkers for early colorectal cancer detection},
journal = {Frontiers in Oncology},
year = {2026},
volume = {16},
doi = {10.3389/fonc.2026.1804433}
}
EUVIMED